PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23558220-0	2013	Decreased tissue levels of cyclophilin A, a cyclosporine a target and phospho-ERK1/2 in simvastatin patients with abdominal aortic aneurysm.	Simvastatin	88-99	peptidylprolyl isomerase A	Homo sapiens	27-40	
23558220-7	2013	RESULTS: The AAA wall tissue from simvastatin-treated patients had significantly lower CyPA gene expression and protein levels (P = 0.0018, P = 0.0083, respectively).	Simvastatin	34-45	peptidylprolyl isomerase A	Homo sapiens	87-91	
23558220-10	2013	CONCLUSION: Simvastatin-treated patients with AAA exert lower CyPA messenger RNA (mRNA), as well as CyPA intracellular protein levels and a decreased amount of phospho-ERK1/2.	Simvastatin	12-23	peptidylprolyl isomerase A	Homo sapiens	62-66	
23558220-10	2013	CONCLUSION: Simvastatin-treated patients with AAA exert lower CyPA messenger RNA (mRNA), as well as CyPA intracellular protein levels and a decreased amount of phospho-ERK1/2.	Simvastatin	12-23	peptidylprolyl isomerase A	Homo sapiens	100-104	
16527992-12	2006	Simvastatin (3 to 30 micromol/L) also dose-dependently inhibited LY83583-induced CyPA secretion likely via decreased isoprenylation of small GTPases.	Simvastatin	0-11	peptidylprolyl isomerase A	Homo sapiens	81-85